PharmacoEconomics Spanish Research Articles

, Volume 2, Issue 1, pp 31–43 | Cite as

Calidad de vida relacionada con la salud: definición y utilización en la práctica médica

  • M. A. Ruiz
  • A. Pardo
Artículo De Revisión

Resumen

En este trabajo se revisa el concepto de calidad de vida relacionada con la salud, su definición, su composición, su medición y su utilización. Se enfatizan el hecho de que se trata de un concepto compuesto por varias dimensiones y los problemas que entraña su interpretación debido a este hecho. La CVRS es uno de los conceptos más consolidados dentro de la IRS; permite incorporar con facilidad la perspectiva del paciente a los estudios médicos y, en especial, a los fármaco-económicos.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografía

  1. 1.
    Bungay K, Boyer JG, Steinwald AB, Ware JE. Health-Related Quality of Life: An Overview. En: Bootman JL, Townsend RJ, McGhan WF. Principles of Pharmacoeconomics 2nd edition. Cincinati: Harvey Whitney Books Company, 1996Google Scholar
  2. 2.
    Bulpit CJ. Quality of life as an outcome measure. Postgrad Med J 1997; 73: 613–6CrossRefGoogle Scholar
  3. 3.
    Kind P. The Role of Quality of Life Measurement in Economic Evaluation: Lessons from the National Health Service. En: Pinto JL, López-Casanovas, Ortún V. (Eds). Economic Evaluation: From theory to practice. Barcelona: Spinger-Verlag Ibérica, 2001Google Scholar
  4. 4.
    Shikiar R, Rentz A. Satisfaction with medication: An overview of conceptual, methodological, and regulatory issues. ISPOR 2004; 7: 204–15Google Scholar
  5. 5.
    Badía X. ¿Qué es Satisfacción y Preferencias con el tratamiento? Madrid; Departamento de Farmacoeconomía, Roche, 2005Google Scholar
  6. 6.
    Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67–74PubMedCrossRefGoogle Scholar
  7. 7.
    Albrecht G, Hoogstraten J. Satisfaction as a determinant of compliance. Community Dentistry and Oral Epidemiology 1998; 26: 139–46PubMedCrossRefGoogle Scholar
  8. 8.
    Ruiz, MA, Villasante F, León F, González-Lara V, González C, Crespo M, Rejas J, Soto J. Cuestionario sobre calidad de vida asociada a dispepsia. Adaptación española y validación del cuestionario Dyspepsia Related Health Scale. Med Clin 2001; 117: 567–73Google Scholar
  9. 9.
    Richard M, Reig A, Cabrero J. La Calidad de vida en la vejez. Sus determinantes biológicos, psicológicos y sociales. Alicante: Editorial Club Universitario, 1999Google Scholar
  10. 10.
    Guyatt GH, Veldhuyzen van Zanten SJO, Feeny DH, Patrick DL. Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J 1989; 140: 1441–8Google Scholar
  11. 11.
    Badía X, Salamero M, Alonso J. La medida de la salud. Guía de escalas de medición en español. Barcelona: Edimac, 2002Google Scholar
  12. 12.
    Red IRYSS. http://www.rediryss.net/pub/units/rediryss/html/es/ dir279/index.html. Línea de investigación 3.2. [Acceso 8 marzo 2005]
  13. 13.
    Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute, 1993Google Scholar
  14. 14.
    Alonso J, Prieto L, Antó JM. Versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de resultados clínicos. Med Clin 1995; 104: 771–6Google Scholar
  15. 15.
    Ware JE, Kosinski M, Keller SD. A 12 Item Sort-Form Health Survey. Construction of Scales and Preliminary Tests of Reliability and Validity. Med Care 1996, 34: 220–33PubMedCrossRefGoogle Scholar
  16. 16.
    Brooks R et al. EuroQol: The current state of play. Health Policy 1996; 37: 53–72PubMedCrossRefGoogle Scholar
  17. 17.
    Badía X, Roset M, Montserrat S, Herdman M, Segura A. La versión española del EuroQoL: descripción y aplicaciones. Med Clin 1999; 112(Supl 1): 79–86Google Scholar
  18. 18.
    Hunt SM. Nottingham Health Profile. In: Wenger NK, Mattson ME, Furberg CD, Elison J, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Washington DC: Le Jacq Press, 1984Google Scholar
  19. 19.
    Barry MJ, Fowler JR, O’leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK and the Measurement committee of the American Urological Association: The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol 1992; 148: 1549–57PubMedGoogle Scholar
  20. 20.
    Bellamy N, Buchanan WW. Outcome measurement in osteoarthritis clinical trials: the case of standardisation. Clinical Rheumatology 1984; 3: 193–303CrossRefGoogle Scholar
  21. 21.
    Kuykendall DH, Rabeneck L, Campbell CJM, Wray NP. Dyspepsia: how should we measure it? J Clin Epidemiol 1998; 51: 99–106PubMedCrossRefGoogle Scholar
  22. 22.
    Cook KF, Rabeneck L, Campbell CJM, Wray NP. Evaluation of a multidimensional measure of dyspepsia-related health for use in a randomized clinical trial. J Clin Epidemiol 1999; 52: 381–92PubMedCrossRefGoogle Scholar
  23. 23.
    Jones PW, Quirck FH, Baveystock CM. The St Georges’s Respiratory Questionnaire. Respiratory Medicine 1991; 85: 25–31PubMedCrossRefGoogle Scholar
  24. 24.
    Wu AW, Rubin HR, Mathews WC, Ware JE, Brysk LT, Hardy WD, Bozzette SA, Spector SA, Richman DD. A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection. Med Care 1991; 29(8): 786–98PubMedCrossRefGoogle Scholar
  25. 25.
    Revicki DA, Sorensen S, Wu AW. Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care 1998; 36: 126–37PubMedCrossRefGoogle Scholar
  26. 26.
    Diabetes Control and Complications Trial (DCCT). Reliability and Validity of a Diabetes Quality of Life Measure for the diabetes Control and Complications Trial (DCCT). Diabetes Care 1988; 11: 725–32CrossRefGoogle Scholar
  27. 27.
    Badía X. The use of Quality of Life Instruments in Health Surveys: their Relevance for Decision-Making. En: Pinto JL, López-Casanovas, Ortún V. (Eds). Economic Evaluation: From theory to practice. Spinger-Verlag Ibérica, 2001Google Scholar
  28. 28.
    Fernández Ballesteros R, Maciá A. Calidad de vida en la vejez. Intervención Psicosocial 1983; 2: 77–94Google Scholar
  29. 29.
    Montorio I, Izal M. Successful aging. But, why don’t the elderly get more depressed? Psychology in Spain 1998; 2: 27–46Google Scholar
  30. 30.
    Fernández-Ballesteros R, Zamarrón MD, Ruiz MA. The contribution of socio-demographic and psychosocial factors to life satisfaction. Ageing and Society 2001: 21; 25–43CrossRefGoogle Scholar
  31. 31.
    Black D, Morris JN, Smith C & Townsend P. Inequalities in health. The Black Report, Middlesex, Penguin Books, 1982Google Scholar
  32. 32.
    Wilkin D. Conceptual problems in dependency research. Social Science and Medicine 1987; 24: 867–73PubMedCrossRefGoogle Scholar
  33. 33.
    Bowling A. Measuring health: a review of quality of life measurement scales. Open University Press, 1992Google Scholar
  34. 34.
    Izal M, Montorio I. Determinantes del Bienestar Psicológico en la Vejez. Rev Argentina Psicol Clínica 1993; 2: 147–59Google Scholar
  35. 35.
    Testa MA, Simmonson DC. Assessment of quality of life outcomes. N Eng J Med 1996; 334: 835–40CrossRefGoogle Scholar
  36. 36.
    Revicki DA, Osoba D, Fairclough D, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000; 9: 887–900PubMedCrossRefGoogle Scholar
  37. 37.
    Papani colaou S, Sykes D, Mossaialos E. EMEA and the evaluation of health-related quality of life data in the drug regulatory process. Int J health Tecn Assess Health Care 2004; 20: 311–24Google Scholar
  38. 38.
    National Center of Biotechnology Information. http://www.ncbi.nlm.nih.gov/ [Acceso 8 de marzo de 2005]
  39. 39.
    Croog SH, Levine S, Testa MA et al. The effects of antihypertensive therapy on the quality of life. N Eng J Med 1986; 314: 1657–64CrossRefGoogle Scholar
  40. 40.
    Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81–7PubMedCrossRefGoogle Scholar
  41. 41.
    Alonso J. La medida de la calidad de vida relacionada con la salud en la investigación y la práctica clínica. Gac Sanit 2000; 14: 163–7PubMedGoogle Scholar
  42. 42.
    Rumsfeld JS, Whinney SM, McCarthy M, et al. health-Related Quality of Life as a Predictor of Mortality Following Coronary Artery Bypass Graft Surgery. JAMA 1999; 281: 1298–1303PubMedCrossRefGoogle Scholar
  43. 43.
    Krumholz HM, Mchorney CA, Clark L, et al. Changes in health after elective percutaneous coronary revascularization. Med Care 1996; 34: 754–9PubMedCrossRefGoogle Scholar
  44. 44.
    Permanyer-Miralda G, Alonso J, Antó JM, et al. Comparison of perceived health status and conventional functional evaluation in stable patients with coronary artery disease. J Clin Epidemiol 1991; 44: 779–86PubMedCrossRefGoogle Scholar
  45. 45.
    Cyr PL, Lenhart G. Short form SF-12 as a predictor of healthcare expenditure in individuals over 65 years of age. Medical Decision Making 1998; 4: 459Google Scholar
  46. 46.
    Miilunpalo S, Vuori I, Oja P, et al. Self-rated health status as a health measure: The predictive value of self-reported health status on the use of physician services and on mortality in the working-age population. J Clin Epidemiol 1997; 5: 517–28CrossRefGoogle Scholar
  47. 47.
    Lundberg L, Johannesson M, Isacson D, et al. The relationship between Health-state utilities and the SF-12 in a General Population. Med Decis Making 1999; 19: 128–40PubMedCrossRefGoogle Scholar
  48. 48.
    Furlong W, Feeny D, Torrance G, Goldsmith C, DePauw S, Zhu Z, Denton M, Boyle M. Multiplicative Multi-Attribute Utility Function for the Health Utilities Index Mark3 (HUI3) System: A Technical Report. Hamilton: McMaster University Center for Health Economics and Policy Analysis, 1998Google Scholar
  49. 49.
    Dolan P. Modelling Valuations for EuroQoL Health States. Med Care 1997; 35: 1095–1108PubMedCrossRefGoogle Scholar
  50. 50.
    Ruiz MA, Rejas J, Soto J, Pardo A, Rebollo I. Adaptación y validación del Health Utilities Index Mark 3 al castellano y baremos de corrección en la población Española. Med Clín 2003; 120: 89–96.CrossRefGoogle Scholar
  51. 51.
    Ruiz MA, Rebollo I, Bermejo F, Rejas J. Adaptation of the HUI-MARK3 to elder population. 10th Annual Conference of the International Society for Quality of Life Research (ISOQOL). Prague, 2003Google Scholar
  52. 52.
    Nord E. Measuring Population Health: an Organisation for Economic Cooperation and Development Survey of Multi-Attribute Utility Instruments. En: Pinto JL, López-Casanovas, Ortún V (Eds.). Economic Evaluation: From theory to practice. Barcelona: Spinger-Verlag Ibérica, 2001Google Scholar
  53. 53.
    Badía X. Sobre la adaptación transcultural de medidas de calidad de vida relacionada con la salud para uso en España. Med Clin 1995; 105: 56–8Google Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • M. A. Ruiz
    • 1
  • A. Pardo
    • 1
  1. 1.Universidad Autónoma de MadridEspaña

Personalised recommendations